Terry Murdock
Chief Operating Officer at G1 THERAPEUTICS, INC.
Net worth: 400 043 $ as of 2024-04-29
Terry Murdock active positions
Companies | Position | Start | End |
---|---|---|---|
G1 THERAPEUTICS, INC. | Chief Operating Officer | 2018-12-31 | - |
Corporate Officer/Principal | 2017-08-02 | - |
Career history of Terry Murdock
Former positions of Terry Murdock
Companies | Position | Start | End |
---|---|---|---|
IQVIA HOLDINGS INC. | Corporate Officer/Principal | 2014-08-31 | 2017-06-30 |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | Chief Operating Officer | 2000-12-31 | 2012-04-30 |
The US Oncology Network | Corporate Officer/Principal | 1994-12-31 | 2000-12-31 |
ERGOMED | Chief Tech/Sci/R&D Officer | - | - |
Training of Terry Murdock
The University of Texas at Austin | Graduate Degree |
Statistics
International
United States | 6 |
United Kingdom | 2 |
Operational
Corporate Officer/Principal | 3 |
Chief Operating Officer | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Sectoral
Health Technology | 3 |
Commercial Services | 2 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 3 |
---|---|
ERGOMED | Commercial Services |
G1 THERAPEUTICS, INC. | Health Technology |
IQVIA HOLDINGS INC. | Health Services |
Private companies | 2 |
---|---|
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | Health Technology |
The US Oncology Network |
- Stock Market
- Insiders
- Terry Murdock
- Experience